Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD

References

• DonaldsonGCWedzichaJAThe causes and consequences of seasonal variation in COPD exacerbationsInt J Chron Obstruct Pulmon Dis201491101111025336941
   PubMed Web of Science ®Google Scholar
• DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
   PubMed Web of Science ®Google Scholar
• SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1998157141814229603117
   PubMed Web of Science ®Google Scholar
• Soler-CataluñaJJMartínez-GarcíaMARomán SánchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax20056092593116055622
   PubMed Web of Science ®Google Scholar
• BhowmikASeemungalTASapsfordRJWedzichaJARelation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbationsThorax20005511412010639527
   PubMed Web of Science ®Google Scholar
• GanWQManSFSenthilselvanAAssociation between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisThorax200459757458015223864
   PubMed Web of Science ®Google Scholar
• Garcia-AymerichJFarreroEFélezMAIzquierdoJMarradesRMAntóJMRisk factors of readmission to hospital for a COPD exacerbation: a prospective studyThorax20035810010512554887
   PubMed Web of Science ®Google Scholar
• PereraWRHurstJRWilkinsonTMInflammatory changes, recovery and recurrence at COPD exacerbationEur Respir J20072952753417107990
   PubMed Web of Science ®Google Scholar
• WoutersEFEconomic analysis of the confronting COPD survey: an overview of resultsRespir Med200397Suppl CS3S1412647938
   PubMed Web of Science ®Google Scholar
• RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med200717653255517507545
   PubMed Web of Science ®Google Scholar
• MarchioniCFMorettiMMuratoriMEffects of erdosteine on sputum biochemical and rheologic properties: pharmacokinetics in chronic obstructive lung diseaseLung1990682852932126836
   PubMed Web of Science ®Google Scholar
• BragaPCDal SassoMSalaMTGianelleVEffects of erdosteine and its metabolites on bacterial adhesivenessArzneimittelforschung199949434435010337454
   PubMed Web of Science ®Google Scholar
• BragaPCDal SassoMZuccottiTAssessment of the antioxidant activity of the SH Metabolite I of erdosteine on human neutrophils respiratory burstsArzneimittelforschung200050873974610994158
   PubMed Web of Science ®Google Scholar
• MorettiMMarchioniCFAn overview of erdosteine antioxidant activity in experimental researchPharmacol Res200755424925417267240
   PubMed Web of Science ®Google Scholar
• Dal NegroRWViscontiMMichelettoCTognellaSChanges in blood ROS, e-NO, and some pro-inflammatory mediators in bronchial secretions following erdosteine or placebo: a controlled study in current smokers with mild COPDPulm Pharmacol Ther200821230430817889580
   PubMed Web of Science ®Google Scholar
• MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
   PubMed Web of Science ®Google Scholar
• LeidyNKRennardSISchmierJJonesMKGoldmanMThe breathlessness, cough and sputum scale: the development of empirically based guidelines for interpretationChest200312462182219114665499
   PubMed Web of Science ®Google Scholar
• AnthonisenNRManfredaJWarrenCPHershfieldESHardingGKNelsonNAAntibiotic therapy in exacerbation of chronic obstructive pulmonary diseaseAnn Intern Med198710621962043492164
   PubMed Web of Science ®Google Scholar
• RicevutiGMazzoneAUccelliEGazzaniGFregnanGBInfluence of erdosteine, a mucolytic agent, on amoxicillin penetration into sputum in patients with an infective exacerbation of chronic bronchitisThorax19884385855903051508
   PubMed Web of Science ®Google Scholar
• MarchioniCFPoluJMTaytardAHanardTNosedaGManciniCEvaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxicillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study)Int J Clin Pharm Ther19953311612618
   PubMed Web of Science ®Google Scholar
• LanglandsJHDouble-blind clinical trial of bromhexine as a mucolytic drug in chronic bronchitisLancet1970176444484504189753
   PubMed Web of Science ®Google Scholar
• BlackPNMorgan-DayAMcMillanTEPoolePJYoungRPRandomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease [ISRCTN21676344]BMC Pulm Med200441315581425
   PubMedGoogle Scholar
• HurstJRDonaldsonGCPereraWRUse of plasma biomarkers at exacerbation of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2006174886787416799074
   PubMed Web of Science ®Google Scholar
• MorettiMPharmacology and clinical efficacy of erdosteine in chronic obstructive pulmonary diseaseExpert Rev Respir Med2007130731620477170
   PubMedGoogle Scholar
• RobertsCMLoweDBucknallCERylandIKellyYPearsonMGClinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary diseaseThorax200257213714111828043
   PubMed Web of Science ®Google Scholar
• HurstJRDonaldsonGCQuintJKGoldringJJBaghai-RavaryRWedzichaJATemporal clustering of exacerbations in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2009179536937419074596
   PubMed Web of Science ®Google Scholar
• DaviesLAngusRMCalverleyPMOral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trialLancet1999354917745646010465169
   PubMed Web of Science ®Google Scholar
• Wood-BakerRWaltersEHGibsonPOral corticosteroids for acute exacerbations of chronic obstructive pulmonary diseaseCochrane Database Syst Rev20012CD00128811405984
   PubMedGoogle Scholar
• MorettiMBottrighiPDallariRThe effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: the EQUALIFE StudyDrugs Exp Clin Res200430414315215553660
   PubMedGoogle Scholar
• CharlsonMEPompeiPAlesKLA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
   PubMedGoogle Scholar
• MaesenFPDaviesBIBrouwersJRubinghGErythromycin and bromhexine in acute exacerbations of chronic bronchitis. A study on sputum penetration and clinical effectivenessEur J Respir Dis19826343253296981522
   PubMedGoogle Scholar
• FiniguerraMContiPFiguraILegnaniWMorandiniGCClinical study on the effects of an antibiotic and mucolytic association (amoxicillin and domiodol) in hypersecretory chronic bronchopulmonary diseasesCurr Ther Res198231895905
   Web of Science ®Google Scholar